Grand Cayman, Cayman Islands

Anirban Kundu


Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anirban Kundu: Innovator in Genetic Modification

Introduction

Anirban Kundu, located in Grand Cayman, KY, is an accomplished inventor with a focus on genetic modification technologies. With two patents to his name, Kundu is making significant strides in the field of cellular therapy.

Latest Patents

Kundu's recent patents showcase innovative methods and compositions aimed at genetically modifying lymphocytes. The first patent details the "Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79B." This invention outlines novel procedures for modifying T cells and NK cells more efficiently and effectively, even within a whole blood environment. Additionally, he presents a lymphodepletion filter assembly to enhance the process.

The second patent, "Methods and compositions for transducing lymphocytes and regulating the activity thereof," elaborates on strategies for genetically altering lymphocytes specifically for adoptive cellular therapy. This work integrates the use of inhibitory RNA molecules and engineered signaling polypeptides, including a microenvironment restricted biologic CAR (MRB-CAR). Kundu's efforts also encompass innovative elements for regulating modified T cells and NK cells, such as riboswitches and pH-modulating agents.

Career Highlights

Anirban Kundu's work in biotechnology, particularly with Exuma Biotech Corp., underscores a commitment to advancing medical treatments. His patents represent a culmination of extensive research aimed at enhancing the efficacy of cellular therapies.

Collaborations

Kundu's collaborations with fellow inventors Gregory Ian Frost and James Joseph Onuffer, Jr. demonstrate his ability to work effectively within teams. Together, they contribute to the development of groundbreaking technologies that hold the potential to transform treatment methodologies in the biotech field.

Conclusion

Anirban Kundu is an influential figure in genetic modification and cellular therapy. His innovative patents offer promising advancements that could significantly change the landscape of medical treatments. As he continues to work with Exuma Biotech Corp., his contributions will undoubtedly inspire future innovations in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…